Anti-ageing compounds
Anti-ageing compounds has been studied in 2 papers since 2024: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, May 18, 2026: “AI-Accelerated Discovery of Novel Gero-suppressive Compounds: Quantifying the Enhancement of the Human Health span-To-Lifespan Ratio”.
2 papers study it4 findingsUpdated
See all 2 papers on anti-ageing compounds
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funders: Biotechnology and Biological Sciences Research Council and 8 more
- Model organisms1
- In silico1
What did studies of anti-ageing compounds find?
3Studies of anti-ageing compounds measured 3 outcomes: cellular senescence, healthspan and oxidative stress and ROS signaling.
Cellular senescence
downin human cells1downin silico1
2 studies
Cellular senescence
downin human cells1downin silico1
Anti-ageing compounds inhibit cellular senescence in silico (computational prediction / screening).
“The selected molecules showed considerable decreases in oxidative stress, inflammation, and cellular senescence markers”
In silicocomputational prediction / screening
Journal of Pharmaceutical Research and Integrated Medical Sciences
Anti-ageing compounds decrease cellular senescence in human primary cells with delayed epigenetic ageing.
“delayed epigenetic ageing in human primary cells treated with anti-ageing compounds is accompanied by a reduction in senescence and ageing biomarkers”
Cellsin human primary cells with delayed epigenetic ageing
An expedited screening platform for the discovery of anti-ageing compounds in vitro and in vivo
Genome medicine
Healthspan
upin silico1
1 study
Healthspan
upin silico1
Anti-ageing compounds improve healthspan in silico (computational prediction / screening).
“quantitative results showed that the use of AI for predicting the efficacy of anti-aging agents led to more significant healthspan enhancements than lifespan increases”
In silicocomputational prediction / screening
Journal of Pharmaceutical Research and Integrated Medical Sciences
Oxidative stress and ROS signaling
downin silico1
1 study
Oxidative stress and ROS signaling
downin silico1
Anti-ageing compounds decrease oxidative stress and ROS signaling in silico (computational prediction / screening).
“The selected molecules showed considerable decreases in oxidative stress, inflammation, and cellular senescence markers”
In silicocomputational prediction / screening
Journal of Pharmaceutical Research and Integrated Medical Sciences